Palminteri R, Kaik G
Eur J Clin Pharmacol. 1983;24(6):741-5. doi: 10.1007/BF00607080.
The effects on specific airway conductance (sGaw) of placebo, betaxolol and propranolol following the inhalation of salbutamol were studied in 8 healthy volunteers by whole body plethysmography. Each subject received placebo and single oral doses of betaxolol 40 mg and 80 mg, and propranolol 160 mg, and 320 mg. sGaw was measured before dosing and after 2 h, just before salbutamol was inhaled. It was then measured again after 15 min and 0.5, 1, 2, 3, 4 and 6 h. sGaw 2 h after the beta-blockers did not differ from the value whilst on placebo. The peak response to salbutamol after placebo and both doses of betaxolol was almost identical, whereas it was significantly reduced after propranolol. The AUC of the response to salbutamol over 6 h showed a reduction of 11% after betaxolol and of 19% after propranolol (p less than 0.01 between beta-blockers). The results indicate that, after betaxolol and in contrast to propranolol, a proportion of the bronchial beta 2-receptor population remains available to a beta 2-agonist.
通过全身体积描记法,在8名健康志愿者中研究了吸入沙丁胺醇后安慰剂、倍他洛尔和普萘洛尔对特定气道传导率(sGaw)的影响。每位受试者接受安慰剂以及单次口服40 mg和80 mg的倍他洛尔,还有160 mg和320 mg的普萘洛尔。在给药前以及给药后2小时(即将吸入沙丁胺醇之前)测量sGaw。然后在15分钟以及0.5、1、2、3、4和6小时后再次测量。β受体阻滞剂给药2小时后的sGaw与服用安慰剂时的值无差异。安慰剂和两种剂量倍他洛尔后沙丁胺醇的峰值反应几乎相同,而普萘洛尔后则显著降低。沙丁胺醇6小时反应的AUC显示,倍他洛尔后降低了11%,普萘洛尔后降低了19%(β受体阻滞剂之间p<0.01)。结果表明,与普萘洛尔不同,倍他洛尔后一部分支气管β2受体群体对β2激动剂仍然可用。